Haicang To Build Fujian-Taiwan Biomedical Innovation Platform
This article was originally published in PharmAsia News
Executive Summary
Amoytop Biotech will soon begin construction on the Fujian-Taiwan Biomedical Technology Innovation Services Platform, located in Xiamen's Haicang Taiwanese Investment Zone